COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Europe Liver Health Supplements Market would witness market growth of 3.92% CAGR during the forecast period (2019-2025).
Increased alcohol consumption across the globe has led to various health problems, including liver problems. In addition, the reduced quality of food and food products due to increased adoption of chemical fertilizers and adulteration of food products affect the function of the liver. The increasing prevalence of chronic disorders is a major driver of the market for liver health supplements. Various novel agents have shown improvements in clinical trials like obeticholic acid, thiazolidinedione and vitamin E for the treatment of non-alcoholic fatty liver disease.
In Europe, increasing the consumption of nutritional products in countries such as Germany and the United Kingdom is expected to encourage the adoption of supplements for liver health during the forecast period. In addition, the increasing adoption of vitamin products, especially among the working population, is anticipated to make a strong impact on regional market growth in the coming years.
One of the main drivers of the demand for liver health supplements is customer awareness of the commercial availability of the liver health supplement products and the health benefits of these products. In addition, the introduction of different platforms to access health supplements such as online apps, online retailers and other e-commerce sites has led to increased liver health supplement use.
Based on Form, the market is segmented into Capsules, Liquids, Tablets, Powders and Other Forms. Based on Product, the market is segmented into Herbal Supplements, Vitamins & Minerals and Other Products. The report also covers geographical segmentation of Liver Health Supplements market. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Nature’s Bounty Co. (The Carlyle Group L.P.), The Himalaya Drug Company (Himalaya Global Holdings Ltd.), NOW Foods, Inc., Integria Healthcare (Australia) Pty Ltd., Enzymedica, Inc., Jarrow Formulas, Inc., Irwin Naturals, Inc., Gaia Herbs, Inc., Swanson Health Products, Inc. (Swander Pace Capital), and Nature’s Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG).
Scope of the Study
Market Segmentation:
By Form

  • Capsules
  • Liquids
  • Tablets
  • Powders and
  • Other Forms


By Product

  • Herbal Supplements
  • Vitamins & Minerals and
  • Other Products


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • The Nature’s Bounty Co. (The Carlyle Group L.P.)
  • The Himalaya Drug Company (Himalaya Global Holdings Ltd.)
  • NOW Foods, Inc.
  • Integria Healthcare (Australia) Pty Ltd.
  • Enzymedica, Inc.
  • Jarrow Formulas, Inc.
  • Irwin Naturals, Inc.
  • Gaia Herbs, Inc.
  • Swanson Health Products, Inc. (Swander Pace Capital)
  • Nature’s Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free